Differences in serum selenoprotein P profile between C57BL/6 and BALB/c mice fed high-fat diet
C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated t...
Saved in:
Published in | Journal of trace elements in medicine and biology Vol. 81; p. 127340 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice.
Male C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels.
The mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice.
Unlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes. |
---|---|
AbstractList | C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice.BACKGROUNDC57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice.Male C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels.METHODSMale C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels.The mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice.RESULTSThe mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice.Unlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes.CONCLUSIONUnlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes. C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these strains also show different expression profiles of selenoprotein P, a diabetes-related hepatokine, after HFD feeding is unclear. We investigated the effects of HFD on body weight, glucose metabolism, and plasma selenoprotein P levels in C57BL/6 and BALB/c mice. Male C57BL/6 and BALB/c mice aged seven weeks were divided into normal diet (ND) and HFD groups. Fasting body weights and blood sugar levels were measured weekly. Blood specimens were collected after 16 h of fasting (in weeks 7, 9, and 11) and after 24 h of subsequent refeeding (in weeks 9 and 11) to analyse plasma selenoprotein P and insulin levels. The mean body weight of the HFD group was consistently higher than that of the ND group for both strains. However, a significant elevation in fasting plasma glucose levels from the early stage was observed only in the HFD group of C57BL/6 mice. In BALB/c mice, a difference in fasting glucose levels between the HFD and ND groups was observed after nine weeks. After seven, nine, and eleven weeks, the fasting plasma insulin levels were higher in the HFD group than in the ND group for both strains. During this period, plasma selenoprotein P levels in the HFD group were significantly higher than those in the ND group of C57BL/6 mice. However, BALB/c mice did not show a significant difference in plasma levels of selenoprotein P between the ND and HFD groups. After refeeding, the plasma insulin and selenoprotein P levels increased compared to those observed during fasting in the ND group for both strains. Elevation of insulin levels, but not of selenoprotein P levels, after refeeding was noticed in the HFD group for both strains. Plasma selenoprotein P level after refeeding was significantly lower than that during fasting in the HFD group of C57BL/6 mice. Unlike C57BL/6 mice, BALB/c mice did not show elevated fasting plasma selenoprotein P levels despite HFD feeding. Additionally, the pattern of selenoprotein P levels in the plasma after refeeding differed between C57BL/6 and BALB/c mice. These differences in selenoprotein P expression among strains may be related to different susceptibilities of individuals to diabetes. |
ArticleNumber | 127340 |
Author | Watanabe, Norio Suzuki, Keiko Kawahara, Masami Kitamoto, Riko Nakayama, Ayako Ando, Motozumi |
Author_xml | – sequence: 1 givenname: Motozumi orcidid: 0000-0003-2473-0588 surname: Ando fullname: Ando, Motozumi – sequence: 2 givenname: Keiko surname: Suzuki fullname: Suzuki, Keiko – sequence: 3 givenname: Riko surname: Kitamoto fullname: Kitamoto, Riko – sequence: 4 givenname: Ayako surname: Nakayama fullname: Nakayama, Ayako – sequence: 5 givenname: Norio surname: Watanabe fullname: Watanabe, Norio – sequence: 6 givenname: Masami surname: Kawahara fullname: Kawahara, Masami |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37984217$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMtOwzAQRS1URB_wBUjISzZJ_YrtLNvylCrBogtWWI4zponyKHEqxN-T0sJmZjQ6uro6UzRq2gYQuqYkpoTKeRmXPdRZzAjjMWWKC3KGJlQrHXGWsBGakFTISCr2NkbTEEpCqEo0u0BjrlItGFUT9H5XeA8dNA4CLhocoNvXw6ygaXdd28Pwe8XD5YsKcAb9F0CDV4larucS2ybHy8V6OXe4LhxgDzneFh_byNse5wX0l-jc2yrA1WnP0ObhfrN6itYvj8-rxTpynNE-SoVIc251JkD5hHOZJBJkQrjNOGXCpZ5Lr73PFJVZygW12lmaeJFZSlzKZ-j2GDsU_dxD6E1dBAdVZRto98EwnTKmqJZyQG9O6D6rITe7rqht923-lAwAPwKua0PowP8jlJiDeFOaX_HmIN4cxfMfm911MQ |
Cites_doi | 10.1016/j.redox.2022.102236 10.1074/jbc.M111.238311 10.1002/hep.22526 10.3758/BF03193146 10.1002/jcp.30121 10.1016/j.freeradbiomed.2013.07.016 10.1074/jbc.C100109200 10.1007/s00125-013-2846-8 10.1016/j.bbalip.2016.08.016 10.1074/jbc.M116.747006 10.1038/bmt.2012.244 10.1016/j.orcp.2016.07.004 10.1128/MCB.00293-12 10.1016/j.jhep.2020.11.030 10.1073/pnas.1213343109 10.1038/s41586-019-1797-8 10.3390/ijms21228838 10.1042/CS20110366 10.1037/0033-2909.112.1.155 10.1016/j.cmet.2010.09.015 |
ContentType | Journal Article |
Copyright | Copyright © 2023 Elsevier GmbH. All rights reserved. |
Copyright_xml | – notice: Copyright © 2023 Elsevier GmbH. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jtemb.2023.127340 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1878-3252 |
ExternalDocumentID | 37984217 10_1016_j_jtemb_2023_127340 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29L 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 88I 8AF 8FE 8FH 8FI 8FJ 8P~ 8R4 8R5 AAEDT AAEDW AAIKJ AAKOC AAKPP AALRI AAOAW AAQFI AAQXK AARLI AATTM AAXKI AAXUO AAYWO AAYXX ABBQC ABFNM ABFRF ABFYP ABGSF ABJNI ABKYH ABLST ABMAC ABMZM ABRWV ABUDA ABUWG ABWVN ABXDB ABZDS ACDAQ ACGFO ACGFS ACGOD ACIEU ACJTP ACMHX ACNNM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADECG ADEZE ADKUU ADMUD ADNMO ADSLC ADUVX ADVLN AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEXOQ AFJKZ AFKRA AFPUW AFTJW AFXBA AFXIZ AFZHZ AGCQF AGHFR AGQPQ AGRDE AGRNS AGUBO AGWPP AGYEJ AHEUO AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJSZI AKBMS AKIFW AKRWK AKYEP ALCLG ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BENPR BES BHPHI BKOJK BLECG BLXMC BNPGV BPHCQ BVXVI CCPQU CITATION CS3 DWQXO EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ HCIFZ HMCUK HVGLF HX~ HZ~ IHE J1W KCYFY KOM LK8 M1P M2P M2Q M41 M7P MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. PHGZM PHGZT PQQKQ PROAC PSQYO PZZ Q2X Q38 R2- RIG ROL RPZ S0X SCB SDF SDG SES SEW SNG SNL SPC SPCBC SSH SSJ SSK SSP SSU SSZ T5I T5J T5K UKHRP UNMZH ~G- AACTN CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c321t-9449d3a8b4e7f5336556e6503ab3124c9f36f8ffb716b9341a8ca15f4ba10c93 |
ISSN | 0946-672X 1878-3252 |
IngestDate | Fri Jul 11 07:03:10 EDT 2025 Thu Apr 03 07:05:21 EDT 2025 Tue Jul 01 03:22:37 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Type 2 diabetes Insulin resistance Hyperglycaemia Selenoprotein P Hepatokine High fat diet |
Language | English |
License | Copyright © 2023 Elsevier GmbH. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c321t-9449d3a8b4e7f5336556e6503ab3124c9f36f8ffb716b9341a8ca15f4ba10c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2473-0588 |
PMID | 37984217 |
PQID | 2892271866 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2892271866 pubmed_primary_37984217 crossref_primary_10_1016_j_jtemb_2023_127340 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-01-00 2024-Jan 20240101 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-00 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Journal of trace elements in medicine and biology |
PublicationTitleAlternate | J Trace Elem Med Biol |
PublicationYear | 2024 |
References | Kupriyanova (10.1016/j.jtemb.2023.127340_bib9) 2021; 74 Steinbrenner (10.1016/j.jtemb.2023.127340_bib1) 2013; 65 Faul (10.1016/j.jtemb.2023.127340_bib13) 2007; 39 Tajima-Shirasaki (10.1016/j.jtemb.2023.127340_bib18) 2017; 292 Chen (10.1016/j.jtemb.2023.127340_bib4) 2021; 236 Caviglia (10.1016/j.jtemb.2023.127340_bib6) 2020; 21 Speckmann (10.1016/j.jtemb.2023.127340_bib20) 2008; 48 Misu (10.1016/j.jtemb.2023.127340_bib7) 2010; 12 Seale (10.1016/j.jtemb.2023.127340_bib8) 2012; 32 Cohen (10.1016/j.jtemb.2023.127340_bib14) 1992; 112 Montgomery (10.1016/j.jtemb.2023.127340_bib16) 2016; 1861 Owen (10.1016/j.jtemb.2023.127340_bib17) 2012; 109 Roden (10.1016/j.jtemb.2023.127340_bib3) 2019; 576 Montgomery (10.1016/j.jtemb.2023.127340_bib11) 2013; 56 Maina (10.1016/j.jtemb.2023.127340_bib15) 2012; 122 Steinbrenner (10.1016/j.jtemb.2023.127340_bib10) 2022; 50 Motamed (10.1016/j.jtemb.2023.127340_bib19) 2011; 286 Chen (10.1016/j.jtemb.2023.127340_bib5) 2017; 11 Kanda (10.1016/j.jtemb.2023.127340_bib12) 2013; 48 Mahadev (10.1016/j.jtemb.2023.127340_bib2) 2001; 276 |
References_xml | – volume: 50 year: 2022 ident: 10.1016/j.jtemb.2023.127340_bib10 article-title: The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities publication-title: Redox Biol. doi: 10.1016/j.redox.2022.102236 – volume: 286 start-page: 18002 year: 2011 ident: 10.1016/j.jtemb.2023.127340_bib19 article-title: Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.238311 – volume: 48 start-page: 1998 year: 2008 ident: 10.1016/j.jtemb.2023.127340_bib20 article-title: Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors publication-title: Hepatology doi: 10.1002/hep.22526 – volume: 39 start-page: 175 year: 2007 ident: 10.1016/j.jtemb.2023.127340_bib13 article-title: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences publication-title: Behav. Res. Methods doi: 10.3758/BF03193146 – volume: 236 start-page: 3800 year: 2021 ident: 10.1016/j.jtemb.2023.127340_bib4 article-title: SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway publication-title: J. Cell Physiol. doi: 10.1002/jcp.30121 – volume: 65 start-page: 1538 year: 2013 ident: 10.1016/j.jtemb.2023.127340_bib1 article-title: Interference of selenium and selenoproteins with the insulin-regulated carbohydrate and lipid metabolism publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2013.07.016 – volume: 276 start-page: 21938 year: 2001 ident: 10.1016/j.jtemb.2023.127340_bib2 article-title: Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade publication-title: J. Biol. Chem. doi: 10.1074/jbc.C100109200 – volume: 56 start-page: 1129 year: 2013 ident: 10.1016/j.jtemb.2023.127340_bib11 article-title: Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding publication-title: Diabetologia doi: 10.1007/s00125-013-2846-8 – volume: 1861 start-page: 1828 year: 2016 ident: 10.1016/j.jtemb.2023.127340_bib16 article-title: Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: a beneficial role for very long-chain sphingolipid species publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbalip.2016.08.016 – volume: 292 start-page: 10791 year: 2017 ident: 10.1016/j.jtemb.2023.127340_bib18 article-title: Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes publication-title: J. Biol. Chem. doi: 10.1074/jbc.M116.747006 – volume: 48 start-page: 452 year: 2013 ident: 10.1016/j.jtemb.2023.127340_bib12 article-title: Investigation of the freely available easy-to-use software “EZR” for medical statistics publication-title: Bone Marrow Transpl. doi: 10.1038/bmt.2012.244 – volume: 11 start-page: 227 year: 2017 ident: 10.1016/j.jtemb.2023.127340_bib5 article-title: Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance publication-title: Obes. Res Clin. Pract. doi: 10.1016/j.orcp.2016.07.004 – volume: 32 start-page: 4141 year: 2012 ident: 10.1016/j.jtemb.2023.127340_bib8 article-title: Disruption of the selenocysteine lyase-mediated selenium recycling pathway leads to metabolic syndrome in mice publication-title: Mol. Cell Biol. doi: 10.1128/MCB.00293-12 – volume: 74 start-page: 1028 year: 2021 ident: 10.1016/j.jtemb.2023.127340_bib9 article-title: Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.11.030 – volume: 109 start-page: 16184 year: 2012 ident: 10.1016/j.jtemb.2023.127340_bib17 article-title: Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1213343109 – volume: 576 start-page: 51 year: 2019 ident: 10.1016/j.jtemb.2023.127340_bib3 article-title: The integrative biology of type 2 diabetes publication-title: Nature doi: 10.1038/s41586-019-1797-8 – volume: 21 year: 2020 ident: 10.1016/j.jtemb.2023.127340_bib6 article-title: Interplay between oxidative stress and metabolic derangements in non-alcoholic fatty liver disease: the role of selenoprotein P publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21228838 – volume: 122 start-page: 545 year: 2012 ident: 10.1016/j.jtemb.2023.127340_bib15 article-title: Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice publication-title: Clin. Sci. doi: 10.1042/CS20110366 – volume: 112 start-page: 155 year: 1992 ident: 10.1016/j.jtemb.2023.127340_bib14 article-title: A power primer publication-title: Psychol. Bull. doi: 10.1037/0033-2909.112.1.155 – volume: 12 start-page: 483 year: 2010 ident: 10.1016/j.jtemb.2023.127340_bib7 article-title: A liver-derived secretory protein, selenoprotein P, causes insulin resistance publication-title: Cell Metab. doi: 10.1016/j.cmet.2010.09.015 |
SSID | ssj0017582 |
Score | 2.3529487 |
Snippet | C57BL/6 mice generally show hyperglycaemia and insulin resistance when fed a high-fat diet (HFD) compared to those of BALB/c mice. However, whether these... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database |
StartPage | 127340 |
SubjectTerms | Animals Blood Glucose - metabolism Body Weight Diabetes Mellitus Diet, High-Fat - adverse effects Insulins Male Mice Mice, Inbred BALB C Mice, Inbred C57BL Selenoprotein P |
Title | Differences in serum selenoprotein P profile between C57BL/6 and BALB/c mice fed high-fat diet |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37984217 https://www.proquest.com/docview/2892271866 |
Volume | 81 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BeuGCgPIILy0S4mKcxt7165iUVoGmoQdXyglrvd6V0so2KvYh-fXMPhwnIkiFyyqZOLvRzJfRvHYGoY8BYZRSGbtEhjE4KAFx85DDQjwiC68Qhc7oXi7C2TX9tgyWfUxX3y5p8hHfHLxX8j9SBRrIVd2S_QfJbjcFArwG-cIKEob1XjL-YqebmKoqB85sS0eNT6pq3X8BaFeOncq9rcg6DaLpHM4Mdd5gOplP4Q131Fh6R4L5qRoYu5I1TrESe4H7Hdu1uWPwtDCl5_rsLkevN7WdnfoQQ6EDspd1U2_actUnojatmZp9IVa3dV8O0DAAUG3u_ff0Bbtla1aaQPCa2Q9sxMKnOxELo2RjVZLhm861I3GAZjWzGeZiVaunGvGMD2p9E4C4AXaIMh-pgfCj_un9HtuL79n59XyepWfL9CE68sG58AfoaPL1YrbYZp_Ah9JZ8u43dd2qdF3gH4fsWzR_cVO0uZI-QY-trPDEgOYpeiCqZ-h4UrGmLtf4E9aVv1pKx-jHDo7wqsIaR3gPR_gKWxxhiyOscXQSYhA4Vig64VhhCAOGcIchrDD0HKXnZ-npzLVzN1xOfK9xE0qTgrA4pyKS4A6EQRAKsOQJg3-wT3kiSShjKXPwtfMEzCAWc-YFkubMG_OEvECDqq7EK4TjImdg01LuRYyKIIijgiWc5uOkKDwq-RB97liX_TTdVbKu7PAm05zOFKczw-kh-tCxNwMtqFJbrBJ1-yvz48T3I9W8cYheGr5vNyRRElPwvF_f49tv0KMesW_RoLlrxTuwOpv8vQXJb7YKgRo |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+serum+selenoprotein+P+profile+between+C57BL%2F6+and+BALB%2Fc+mice+fed+high-fat+diet&rft.jtitle=Journal+of+trace+elements+in+medicine+and+biology&rft.au=Ando%2C+Motozumi&rft.au=Suzuki%2C+Keiko&rft.au=Kitamoto%2C+Riko&rft.au=Nakayama%2C+Ayako&rft.date=2024-01-01&rft.issn=1878-3252&rft.eissn=1878-3252&rft.volume=81&rft.spage=127340&rft_id=info:doi/10.1016%2Fj.jtemb.2023.127340&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-672X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-672X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-672X&client=summon |